FDA Approves First Treatment for Rett Syndrome
Approval of Daybue applies to adults and children aged 2 years and older
SIDS Rates Increased Significantly From 2019 to 2020
Sudden unexplained infant death rates increased among non-Hispanic Black infants, but not overall
Naloxone Access Not Linked to Teen Substance Use
Naloxone access and pharmacy naloxone distribution not tied to more adolescent heroin, injection drug use
High Number of Health Care Encounters Seen for Tap Water Scalds
Furthermore, from 2016 to 2018, tap water scald burns cost $206.7 million in direct health care costs
Minimal Change in Mental Health Linked to COVID-19
In general population studies, no change observed in general mental health or anxiety symptoms; minimal worsening seen in depression symptoms
More Than 3 Million ‘Calico Critters’ Toys Recalled After Two Choking Deaths
A 2-year-old died in 2018 in New Mexico and a 9-month-old died in 2015 in Japan
Preterm Birth Drug Pulled From Market Over Lack of Effectiveness
FDA has been proposing to remove Makena from the market since October 2020, a decision appealed by the drug maker
Febrile Urinary Tract Infections Common With Neurogenic Bladder
Progression to chronic kidney disease grade 3 to 5 increases substantially after four or more febrile urinary tract infections
Cleft Procedures Undervalued Relative to Craniofacial Procedures
Most CPT codes in top quartile of efficiency were craniofacial procedures, while cleft procedures were in lowest quartile
